ASH 2011 Conference Coverage
Researchers engineered a molecular on switch that allows tight control over the actions of T cells, laying the groundwork for sharply reducing the side effects of T cell-based treatments.
Use of testosterone therapy has increased in the last decade and the potential long-term risks associated with this therapy have been of concern.
Compared with open surgery, laparascopic surgery fails to improve outcomes for patients with stage 2 or 3 rectal cancer.
Bisphosphonates may improve symptoms of hypercalcemia and prolong survival in patients receiving palliative care.
Nonsmokers more likely than smokers to be women and to have adenocarcinoma
Researchers identified two new cancer-causing gene mutations that could lead to more targeted and effective treatments for certain lung and prostate cancers.
A recent study showed that for certain cancer drugs, participants in clinical trials are often not representative of the patients who ultimately take the drugs, raising questions about the direct applicability of trial data.
Patients' constant proximity to nurses gives them opportunities and the ease of familiarity to ask difficult questions. When answering, nurses should remember that part of the answer is the patient's choice of who to ask.
Researchers have shown that a certain protein becomes overabundant in pancreatic neuroendocrine tumors, allowing them to thrive. They also found that pairing a synthetic compound with an existing drug provides a more effective anticancer punch than a single drug.
What are the most effective treatments for MS pain in patients with co-existing cancer?
- Clinical Trial Shows Vaccine Clears Some Precancerous Cervical Lesions
- Late-Stage Lung Cancer Often Overtreated
- Biomarker May Predict Prognosis for Targeted Therapy in Patients With HER2-Negative Breast Cancer
- New Approach Tackles Hormone Therapy Resistance in Breast Cancer
- Patients With Multiple Myeloma Vulnerable to Financial Toxicity Due to Costly Treatments
- Engineered Switch in Immune Cell Technology Makes Therapy More Precise, and Safer
- Testosterone Therapy Does Not Increase Aggressive Prostate Cancer Risk
- Laparascopic Surgery Does Not Improve Outcomes Over Open Resection for Rectal Cancer
- Bisphosphonates May Be Useful as Palliative Measure in Selected Patients
- Smokers and Nonsmokers Who Develop NSCLC Display Differences
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|